Questioning Medicine
Episode 184: 184. Question and Answer From the Last Two Podcast
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:24:36
- Mas informaciones
Informações:
Sinopsis
I've found that I can often increase compliance with statins by having pt take them 3x/week or QOD. I try this often especially in my secondary prevention group. I understand "any statin is better than none", but do data support this approach? -- any is better than none! No rct with this but yes data supports every other day but that is observational..what about vascepa in reducing CAD risk both primary and secondary risk? Vascepa is now the first and only drug approved by the FDA as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (≥150 mg/dL) and established cardiovascular disease or diabetes mellitus and two or more additional risk factors for cardiovascular diseaseReduce it trial---The big trial which showed all the promise used mineral oil as a placeboAND then we have evaporate trial—which showed steady plaqueThe groups